Compass Pathways (CMPS) announced its common stock will be added to the Nasdaq Biotechnology Index effective prior to market open on Monday, December 23.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPS:
- Rising High: Organigram acquires Motif Labs for C$90M upfront
- Rising High: Cannabis firms report quarterly earnings
- Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
- Atai Life Sciences price target lowered to $10 from $15 at H.C. Wainwright
- Rising High: Exclusive talk with house of brands Carma HoldCo